Registry of Lobbyists

Registration - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Information

In-house Corporation name: AbbVie Corporation
Previous in-house corporation names
Responsible Officer Name: RAMI FAYED, Vice President and General Manager, Canada 
Responsible Officer Change History
Initial registration start date: 2007-04-25
Registration status: Active
Registration Number: 957373-15270

Associated Communications

Total Number of Communication Reports: 142

Monthly communication reports in the last 6 months: 9

Version 1 of 40 (2007-04-25 to 2007-05-01)

Version 1 of 40 (2007-04-25 to 2007-05-01) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Responsible Officer and Corporation

Corporation: Abbott Laboratories, Limited
8401 Transcanada Highway
St-Laurent, QC  H4S 1Z1
Canada
Telephone number: 514-832-7429
Fax number: 514832 7865  
Responsible officer name and position during the period of this registration: Jeffrey Devlin, Director, Government & External Affairs  
Description of activities: Abbott is a broad-based health care company that discovers, develops, manufactures and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals.
 
The client is a subsidiary of the following parent companies: Abbott Laboratories
100 Abbott Park Rd
Abbott Park, IL
United States of America 60064-3500

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Corporation

Name: Martin Cloutier
Position title: Regulatory Affairs, Project Manager
Public offices held: No
 
Name: Loretta Del Bosco
Position title: Director, Regulatory Affairs & Quality Assurance
Public offices held: No
 
Name: Jeffrey Devlin
Position title: President and General Manager
Public offices held: No
 
Name: Laurie Dotto
Position title: Director Government & External Affairs
Public offices held: No
 
Name: Claire Ducharme
Position title: Regulatory Affairs Specialist
Public offices held: No
 
Name: France Guertin
Position title: Regulatory Affairs, Project Manager
Public offices held: No
 
Name: Christine Kor
Position title: Regulatory Affairs Associate
Public offices held: No
 
Name: Michelle LeBlanc
Position title: Drug Safety & Regulatory Compliance Manager
Public offices held: Yes
 
Name: David Link
Position title: National Manager Market Access & Governmental Affairs
Public offices held: No
 
Name: Judith Mergl
Position title: Senior Manager Regulatory Affairs
Public offices held: No
 
Name: Scott Oke
Position title: Provincial Affairs Manager
Public offices held: No
 
Name: Diana Pappas
Position title: Safety Officer
Public offices held: No
 
Name: Diana Parison
Position title: Senior Manager Market Access Planning & HE
Public offices held: No
 
Name: Danielle Rochon
Position title: Safety Officer
Public offices held: No
 
Name: Shady William
Position title: Regulatory Affairs Associate
Public offices held: No
 
Name: Andrew Wynn
Position title: Provincial Affairs Manager
Public offices held: No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Health Canada (HC), Immigration and Refugee Board (IRB), National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Public Service Health Care Plan, Public Works and Government Services Canada, Royal Canadian Mounted Police (RCMP), Veterans Affairs Canada (VAC)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, R&D, Regulatory, Science and Technology, Taxation and Finance, Trade
 
Subject Matter: Retrospective: Communications in relation to:- Commenting on proposed Health Canada policies and guidelines.- National Pharmaceutical Strategy - Cross border trade / Internet Pharmacies - Common Drug Review - Patented Medicine Prices Review Board (PMPRB) (pricing)- Canada's Innovation Strategy (Science & Technology, Research & Development) Canada's Access to Medicine Regime (Jean Chretien Drugs for Africa bill)
Subject Matter: Prospective: Communications in relation to:- Commenting on proposed Health Canada policies and guidelines.- Interacting with Health Canada to challenge proposed changes to the Non Insured Health Benefits (NIHB) for Proton Pump Inhibitors.- National Pharmaceutical Strategy- Cross border trade / Internet Pharmacies- Common Drug Review- PMPRB (pricing)- Canada's Innovation Strategy (Science & Technology, Research & Development)- Canada's Access to Medicine Regime (Jean Chretien Drugs for Africa bill)
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation Health Canada Regulations - in particular: Food & Drugs Regulations




Date Modified: